Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1980-3-24
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3503-10
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:392137-1-Sarcosine-8-Isoleucine Angiotensin II,
pubmed-meshheading:392137-Adult,
pubmed-meshheading:392137-Angiotensin II,
pubmed-meshheading:392137-Blood Pressure,
pubmed-meshheading:392137-Child,
pubmed-meshheading:392137-Female,
pubmed-meshheading:392137-Humans,
pubmed-meshheading:392137-Hypertension,
pubmed-meshheading:392137-Hypertension, Renal,
pubmed-meshheading:392137-Male
|
pubmed:year |
1979
|
pubmed:articleTitle |
[Angiotensin II analogue and essential hypertension].
|
pubmed:publicationType |
Journal Article,
Review
|